Your session is about to expire
← Back to Search
Other
Intermittent Fasting for Prediabetes and Obesity
N/A
Recruiting
Led By Pouneh Fazeli, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men and women, ages 25-45 years
Normal thyroid function
Must not have
Any chronic diseases including hypertension and Type 2 diabetes mellitus
Indication for lipid-lowering therapy in non-diabetics, using the more stringent AHA guideline cutoff (LDL>190 or an estimated 10-year ASCVD risk of >7.5%)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months
Summary
This trial will explore the metabolic effects of fasting, and if those effects, including on bone metabolism, are independent of weight loss.
Who is the study for?
This trial is for men and women aged 25-45 with a BMI between 21-29, normal thyroid function, regular menstrual cycles for women, and a family history of type 2 diabetes. It's not suitable for those on chronic medications, pregnant or breastfeeding individuals, people with certain vitamin deficiencies or high cholesterol risks, those with eating disorders or substance abuse issues.
What is being tested?
The study examines the metabolic effects of intermittent fasting without daily dietary restrictions to see if benefits like weight loss are independent of fasting itself. Participants will undergo fasting protocols alongside counseling sessions aimed at maintaining their current weight.
What are the potential side effects?
While specific side effects aren't listed in the provided information, potential concerns may include negative impacts on bone metabolism due to caloric restriction associated with intermittent fasting.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 25 and 45 years old.
Select...
My thyroid function is normal.
Select...
I have regular menstrual cycles.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a long-term illness like high blood pressure or Type 2 diabetes.
Select...
I need medication to lower my cholesterol as per AHA guidelines.
Select...
I am on long-term medications or birth control pills.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Trabecular bone microarchitecture
Triglyceride carbon content and degree of saturation
Secondary study objectives
Insulin sensitivity
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Fasting with weight maintenanceExperimental Treatment2 Interventions
Subjects will fast one-day per week for 12 weeks and maintain body weight
Group II: FastingExperimental Treatment1 Intervention
Subjects will fast one-day per week for 12 weeks
Group III: CounselingPlacebo Group1 Intervention
Subjects will be counseled on optimal diet and activity recommendations to maintain/achieve a normal BMI (standard of care)
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,896 Total Patients Enrolled
Pouneh Fazeli, MDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
66 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a parent or sibling with type 2 diabetes or a history of gestational diabetes.You are currently using drugs or alcohol regularly.I am between 25 and 45 years old.I am on long-term medications or birth control pills.I need medication to lower my cholesterol as per AHA guidelines.My thyroid function is normal.You have a past history of struggling with an eating disorder.I have regular menstrual cycles.You have done intermittent fasting in the past.I have a long-term illness like high blood pressure or Type 2 diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Fasting with weight maintenance
- Group 2: Counseling
- Group 3: Fasting
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.